Dibucaine Teaching 13

Charting language
Instructed in new medication Dibucaine and in S/E such as hypersensitivity reactions, rash, swelling, burning, stinging and tenderness.

Reviewed November 2017

Reviewed for general reference only. Adapt to your patient, agency policy, and scope of practice.